17.64 USD
-0.2 (-1.12%)
17.66 USD
+0.02 (+0.11%)
ChartMill assigns a Buy % Consensus number of 79% to SMMT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 32.93. This target is 86.69% above the current price.
SMMT was analyzed by 22 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about SMMT.
In the previous month the buy percentage consensus was at a similar level.
SMMT was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-18 | Wolfe Research | Initiate | Peer Perform |
| 2025-10-22 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-10-21 | Barclays | Maintains | Underweight -> Underweight |
| 2025-10-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-20 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-10-20 | Citigroup | Maintains | Buy -> Buy |
| 2025-09-17 | Barclays | Initiate | Underweight |
| 2025-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-08 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-04 | Guggenheim | Initiate | Buy |
| 2025-09-03 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-09-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-19 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-08-19 | Piper Sandler | Initiate | Neutral |
| 2025-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-12 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-07-01 | UBS | Initiate | Buy |
| 2025-07-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-11 | Leerink Partners | Initiate | Underperform |
| 2025-06-02 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-02 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-28 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-25 | Jefferies | Maintains | Buy -> Buy |
| 2025-04-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-26 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-03-21 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-03-12 | Evercore ISI Group | Initiate | Outperform |
| 2025-02-28 | Goldman Sachs | Initiate | Buy |
SUMMIT THERAPEUTICS INC / SMMT FAQ
What do analysts expect the price target to be for SUMMIT THERAPEUTICS INC (SMMT)?
22 analysts have analysed SMMT and the average price target is 32.93 USD. This implies a price increase of 86.69% is expected in the next year compared to the current price of 17.64.
What is the consensus rating for SMMT stock?
The consensus rating for SUMMIT THERAPEUTICS INC (SMMT) is 79.0909 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed SUMMIT THERAPEUTICS INC (SMMT)?
The number of analysts covering SUMMIT THERAPEUTICS INC (SMMT) is 22.